US Patent Issued to Janssen Pharmaceutica on July 22 for "Compositions containing ibrutinib" (Belgian, American Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,698, issued on July 22, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Compositions containing ibrutinib" was invented by Dilip J. Gole (Plainsboro, N.J.), Maristella Bernini (Beerse, Belgium) and Sabine Inghelbrecht (Stekene, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "Discussed herein are pharmaceutical compositions containing Ibrutinib and processes for preparing them. The compositions may be utilized in the treatment of a variety of conditions including, without limitation, B-cell proliferative disorders such as non-Hodgkin lymphoma (diffuse large B cell lymphoma, follicular lymphoma, mantle cell lymphoma or burkitt lymp...